LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/People In The News/Horacek Moves to Allosource
People In The News

Horacek Moves to Allosource

April 25, 2011 1 min read Premium comments

Advertisement

Horacek Moves to Allosource
Photo manipulation by RRY Publications. Source: AlloSource and Wikimedia Commons

Angela Horacek, formerly Global Vice-President of Operations and Quality for nSpire Health, has accepted the position of Vice President of Operations for Allosource. Allosource is one of the largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures and the world’s largest processor of live cellular bone growth substitutes.

In her former position, Horacek was responsible for manufacturing, supply chain, logistics, facilities and quality and regulatory services for three facilities around the world. Prior to her role at nSpire Health she held positions of responsibility with several medical device organizations.

Allosource President and CEO Thomas Cycyota said,

It is with great pleasure that we welcome Angela to the Executive Leadership Team where her industry experience, strategic operational thought processes and exceptional rapport with people will be great assets to our organization.

Allosource has recently expanded into osteobiologics, which help to stimulate natural bone formation and has pioneered the use of mesenchymal stem cells derived from donor adipose tissue for orthopedic applications.

Horacek holds a bachelor’s degree in chemical engineering, an MBA from the University of Louisiana and a master’s degree in Conflict Resolution from the University of Denver.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy